论文部分内容阅读
抽取2013年6月至2015年1月在我院就诊的78例糖尿病合并胃溃疡患者,随机分为对照组和观察组各39例,对照组采用奥美拉唑治疗,观察组采用泮托拉唑治疗,对比两组患者治疗效果并分析糖尿病合并胃溃疡的临床特点。结果:观察组患者治疗有效率明显高于对照组(P<0.05)。78例患者的溃疡发病部位均在胃部,28例病灶直径>10.0mm,39例病灶直径>5.0mm,其余11例病灶直径<5.00mm。结论:糖尿病合并胃溃疡患者应用泮托拉唑治疗可以有效改善患者临床症状。
A total of 78 patients with diabetes mellitus and gastric ulcer who were treated in our hospital from June 2013 to January 2015 were randomly divided into control group and observation group with 39 cases each. The control group was treated with omeprazole, while the observation group was treated with pantoprazole Treatment with azole compared the effects of treatment in both groups and analyzed the clinical features of diabetic patients with gastric ulcer. Results: The effective rate of treatment in observation group was significantly higher than that in control group (P <0.05). 78 cases of ulcer lesions in the stomach, 28 lesions diameter> 10.0mm, 39 lesions diameter> 5.0mm, and the remaining 11 lesions diameter <5.00mm. Conclusion: The application of pantoprazole in diabetic patients with gastric ulcer can effectively improve the clinical symptoms.